Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Outlooks for Pfizer, Arena and Onyx Following Busy May
Outlooks for Pfizer, Arena and Onyx Following Busy May
Outlooks for Pfizer, Arena and Onyx Following Busy May
Submitted by
admin
on May 21, 2012 - 12:28pm
Source:
TheStreet.com
News Tags:
Pfizer
Arena Pharmaceuticals
Onyx
lorcaserin
JAK3 inhibitors
Merck
Carfilzomib
Headline:
Outlooks for Pfizer, Arena and Onyx Following Busy May
Do Not Allow Advertisers to Use My Personal information
